期刊文献+

曲古抑菌素A对SLE患者外周血IL-10和IL-12分泌的影响

Role of histone deacetylase inhibitors on the excretion of IL-10 and IL-12 in the patients with SLE
下载PDF
导出
摘要 目的:探讨组蛋白去乙酰化酶(HDAC)抑制剂对系统性红斑狼疮(SLE)患者外周血全血培养细胞中IL-10和IL-12分泌水平的影响。方法:选取21例SLE患者和10名正常人,采集空腹静脉血标本分为空白组、HDAC抑制剂(曲古抑菌素A,TSA)组、植物血球凝集素/脂多糖(PHA/LPS)刺激组和PHA/LPS+TSA组作体外全血细胞培养,分离培养液上清并应用酶联免疫吸附法(ELISA)检测IL-10和IL-12分泌水平。结果:SLE患者的外周血全血培养细胞IL-12分泌水平明显低于正常人(P<0.01),但IL-10却明显高于正常人(P<0.01);TSA对SLE患者IL-10的分泌有显著抑制作用(P<0.01),而对IL-12则有明显上调作用(P<0.01),但对正常人IL-10和IL-12分泌水平无明显影响;而且SLE患者IL-10和IL-12的分泌水平分别与SLE疾病活动指数(SLEDAI)呈不同程度的正相关和负相关。结论:IL-10分泌水平上调和IL-12下降在SLE的发病中可能起重要作用,TSA对体外培养的外周血多途径激活后的IL-10分泌具有抑制作用,对IL-12具有上调作用,HDAC抑制剂可能是治疗SLE的一种新方法。 Objective: To explore the effect of histone deacetylase inhibitors on the excretion levels of IL - 10 and IL- 12 in patients with SLE. Methods: Twenty- one patients with SLE and 10 heathy volunteers were involved. Peripheral blood samples were collected and cultured with or without PHA/LPS, TSA and PHA/LPS + TSA. After 24 hours of culture, IL- 10 and IL- 12 in euhure supematant were measured by ELISA. Results. The excretion levels of IL - 12 in SLE were significantly lower than those in normal controls ( P 〈 0.01 ), but IL- 10 were significantly higher than nomral controls ( P 〈 0.01 ), and the levels of IL - 10 and IL - 12 were positive and negative correlated with SLE disease active index (SLEDAI) respectively. TSA could inhibit the excretion of IL- 10 significantly ( P 〈 0.01 ) and promote the excretion of IL - 12 significantly ( P 〈 0.01 ). Furthemlore, TSA could not affect the excretion of IL- 10 and IL- 12 in normal controls. Conclusion: Elevated excretion of IL- 10 and depressed IL- 12 in patients with SLE may play an important role in the disease pathogenesis, and TSA may be a new option for the treatment of SLE.
出处 《中国麻风皮肤病杂志》 2006年第9期726-728,共3页 China Journal of Leprosy and Skin Diseases
关键词 系统性红斑狼疮 白细胞介素-10 白细胞介素-12 HDAC抑制剂 systemic lupus erythematosus IL- 10 IL- 12 histone deaeetylase iahibitors
  • 相关文献

参考文献7

  • 1Ishida H,Muchamuel T,Sakaguic S,et al.Continuous administration of anti-interleukin 10 delays onset of autoimmunity in NZB/W mice.J Exp Med 1994; 197:305-310.
  • 2Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI; a disease activity index for lupus patients,the committee on prognosis studies in SLE.Arthritis Rheum 1992; 35:630-640.
  • 3Vigushin DM.Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.Clin Cancer Res 2001 ;7:971-976.
  • 4Vogel LA,Lester TH,Van Cleave VH,et al.Inhibits of murine BI lymphocytes by interleukin-12.Eur J Immunol 1996; 26:219-223.
  • 5Houssian FA,Mascart-Lemone F,Stevens M,et al.IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells(PBMC).Clin Exp Immunol 1997; 108:375.
  • 6Luis L,Weiping Z,Yves L,et al.Role of IL-10 in the B lymphocytes hyperactivity and autoantibody production of human SLE.J Exp Med 1995; 181:839-844.
  • 7Mishra N,Reilly CM,Brown DR,et al.Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.J Clin Invest 2003; 111:539-552.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部